Status:
COMPLETED
Nictavi Tarsus Patch for Managing Lagophthalmos
Lead Sponsor:
Angeline Nguyen
Conditions:
Lagophthalmos
Eligibility:
All Genders
Up to 17 years
Phase:
NA
Brief Summary
Lagophthalmos is the inability to completely close the eyelids, which can be caused by conditions such as facial nerve dysfunction and eyelid scarring. Lagophthalmos causes evaporation of the tears, w...
Detailed Description
The investigators plan to recruit 20 children and adolescents (ages 0 to 17 years, inclusive) from the Children's Hospital Los Angeles (CHLA) ophthalmology clinics who have lagophthalmos affecting one...
Eligibility Criteria
Inclusion
- Patient subjects:
- Between 0 and 17 years old (inclusive)
- Diagnosis of unilateral or bilateral lagophthalmos based upon an eye examination since Jan 1, 2019
- Previously recommended to use an eyelid closure method (such as using medical tape, steristrips, moisture chambers, temporary tarsorrhaphy, etc).
- English-speaking
- Able to participate in an age-appropriate manner for the eye examination
- Parent subjects:
- 18 years or older
- English-speaking
Exclusion
- Patient subjects:
- Presence of corneal abrasion or corneal ulcer on the study eye
- Active use of bandage contact lens in the study eye
- Active dermatitis affecting the eyelids
- Inability to tolerate the Tarsus Patch in clinic
- Inability for complete mechanical closure of the eyelid by any means
- Allergy to adhesive
- Parent subjects:
- Prisoners
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05183282
Start Date
March 30 2022
End Date
December 1 2022
Last Update
July 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los angeles
Los Angeles, California, United States, 90027